vs
劳瑞德教育集团（LAUR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是劳瑞德教育集团的1.1倍（$622.0M vs $541.4M），Royalty Pharma plc净利率更高（34.4% vs 31.7%，领先2.8%），劳瑞德教育集团同比增速更快（27.9% vs 4.8%），过去两年劳瑞德教育集团的营收复合增速更高（40.2% vs 4.6%）
劳瑞德教育集团是总部位于美国佛罗里达州迈阿密的教育运营企业，旗下拥有并运营劳瑞德国际大学体系，在墨西哥、秘鲁设有多个校区，目前于纳斯达克证券交易所公开上市。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LAUR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$541.4M
营收增速更快
LAUR
高出23.1%
4.8%
净利率更高
RPRX
高出2.8%
31.7%
两年增速更快
LAUR
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $541.4M | $622.0M |
| 净利润 | $171.6M | $214.2M |
| 毛利率 | 35.8% | — |
| 营业利润率 | 33.2% | 62.4% |
| 净利率 | 31.7% | 34.4% |
| 营收同比 | 27.9% | 4.8% |
| 净利润同比 | 83.2% | 2.9% |
| 每股收益（稀释后） | $1.14 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LAURRPRX
| Q4 25 | $541.4M | $622.0M | ||
| Q3 25 | $400.2M | $609.3M | ||
| Q2 25 | $524.2M | $578.7M | ||
| Q1 25 | $236.2M | $568.2M | ||
| Q4 24 | $423.4M | $593.6M | ||
| Q3 24 | $368.6M | $564.7M | ||
| Q2 24 | $499.2M | $537.3M | ||
| Q1 24 | $275.4M | $568.0M |
净利润LAURRPRX
| Q4 25 | $171.6M | $214.2M | ||
| Q3 25 | $34.5M | $288.2M | ||
| Q2 25 | $95.1M | $30.2M | ||
| Q1 25 | $-19.5M | $238.3M | ||
| Q4 24 | $93.6M | $208.2M | ||
| Q3 24 | $85.5M | $544.0M | ||
| Q2 24 | $128.1M | $102.0M | ||
| Q1 24 | $-10.8M | $4.8M |
毛利率LAURRPRX
| Q4 25 | 35.8% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | -0.9% | — | ||
| Q4 24 | 32.0% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | 36.1% | — | ||
| Q1 24 | 7.8% | — |
营业利润率LAURRPRX
| Q4 25 | 33.2% | 62.4% | ||
| Q3 25 | 17.9% | 70.1% | ||
| Q2 25 | 36.9% | 36.3% | ||
| Q1 25 | -5.6% | 94.0% | ||
| Q4 24 | 29.3% | 60.9% | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 33.4% | 50.2% | ||
| Q1 24 | 4.0% | -13.0% |
净利率LAURRPRX
| Q4 25 | 31.7% | 34.4% | ||
| Q3 25 | 8.6% | 47.3% | ||
| Q2 25 | 18.1% | 5.2% | ||
| Q1 25 | -8.3% | 41.9% | ||
| Q4 24 | 22.1% | 35.1% | ||
| Q3 24 | 23.2% | 96.3% | ||
| Q2 24 | 25.7% | 19.0% | ||
| Q1 24 | -3.9% | 0.8% |
每股收益（稀释后）LAURRPRX
| Q4 25 | $1.14 | $0.49 | ||
| Q3 25 | $0.23 | $0.67 | ||
| Q2 25 | $0.65 | $0.07 | ||
| Q1 25 | $-0.13 | $0.55 | ||
| Q4 24 | $0.60 | $0.46 | ||
| Q3 24 | $0.56 | $1.21 | ||
| Q2 24 | $0.83 | $0.23 | ||
| Q1 24 | $-0.07 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.7M | $618.7M |
| 总债务越低越好 | $73.1M | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $2.2B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.06× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LAURRPRX
| Q4 25 | $146.7M | $618.7M | ||
| Q3 25 | $241.0M | $938.9M | ||
| Q2 25 | $135.3M | $631.9M | ||
| Q1 25 | $109.8M | $1.1B | ||
| Q4 24 | $91.3M | $929.0M | ||
| Q3 24 | $134.4M | $950.1M | ||
| Q2 24 | $128.8M | $1.8B | ||
| Q1 24 | $126.2M | $843.0M |
总债务LAURRPRX
| Q4 25 | $73.1M | $9.0B | ||
| Q3 25 | $70.6M | $8.9B | ||
| Q2 25 | $78.1M | $8.0B | ||
| Q1 25 | $91.0M | $7.6B | ||
| Q4 24 | $59.0M | $7.6B | ||
| Q3 24 | $129.8M | $7.6B | ||
| Q2 24 | $203.0M | $7.6B | ||
| Q1 24 | $176.6M | $6.1B |
股东权益LAURRPRX
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $908.5M | $9.8B | ||
| Q4 24 | $959.5M | $10.3B | ||
| Q3 24 | $897.7M | $10.3B | ||
| Q2 24 | $918.0M | $9.8B | ||
| Q1 24 | $933.6M | $9.9B |
总资产LAURRPRX
| Q4 25 | $2.2B | $19.6B | ||
| Q3 25 | $2.1B | $19.3B | ||
| Q2 25 | $2.0B | $18.3B | ||
| Q1 25 | $1.9B | $17.6B | ||
| Q4 24 | $1.9B | $18.2B | ||
| Q3 24 | $1.9B | $18.0B | ||
| Q2 24 | $2.1B | $17.7B | ||
| Q1 24 | $2.2B | $16.1B |
负债/权益比LAURRPRX
| Q4 25 | 0.06× | 0.92× | ||
| Q3 25 | 0.06× | 0.93× | ||
| Q2 25 | 0.07× | 0.84× | ||
| Q1 25 | 0.10× | 0.78× | ||
| Q4 24 | 0.06× | 0.74× | ||
| Q3 24 | 0.14× | 0.74× | ||
| Q2 24 | 0.22× | 0.78× | ||
| Q1 24 | 0.19× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $93.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $26.4M | — |
| 自由现金流率自由现金流/营收 | 4.9% | — |
| 资本支出强度资本支出/营收 | 12.4% | — |
| 现金转化率经营现金流/净利润 | 0.54× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $263.1M | — |
8季度趋势，按日历期对齐
经营现金流LAURRPRX
| Q4 25 | $93.4M | $827.1M | ||
| Q3 25 | $141.0M | $702.6M | ||
| Q2 25 | $74.1M | $364.0M | ||
| Q1 25 | $57.8M | $596.1M | ||
| Q4 24 | $40.7M | $742.5M | ||
| Q3 24 | $118.7M | $703.6M | ||
| Q2 24 | $40.2M | $658.2M | ||
| Q1 24 | $33.2M | $664.6M |
自由现金流LAURRPRX
| Q4 25 | $26.4M | — | ||
| Q3 25 | $122.8M | — | ||
| Q2 25 | $60.8M | — | ||
| Q1 25 | $53.2M | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $110.7M | — | ||
| Q2 24 | $29.5M | — | ||
| Q1 24 | $17.3M | — |
自由现金流率LAURRPRX
| Q4 25 | 4.9% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 22.5% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 30.0% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 6.3% | — |
资本支出强度LAURRPRX
| Q4 25 | 12.4% | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 5.8% | — |
现金转化率LAURRPRX
| Q4 25 | 0.54× | 3.86× | ||
| Q3 25 | 4.09× | 2.44× | ||
| Q2 25 | 0.78× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 0.43× | 3.57× | ||
| Q3 24 | 1.39× | 1.29× | ||
| Q2 24 | 0.31× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAUR
| Mexico Segment | $275.9M | 51% |
| Peru Segment | $265.5M | 49% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
